Reumatoloxía
Servizo
Santos
Castañeda Sanz
Publicacións nas que colabora con Santos Castañeda Sanz (148)
2024
-
Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up
Seminars in Arthritis and Rheumatism, Vol. 66
-
Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register
RMD open, Vol. 10, Núm. 1
-
Leflunomide as a therapeutic alternative to methotrexate as a glucocorticoid-sparing agent in polymyalgia rheumatica
Rheumatology Advances in Practice
-
Lights and shadows on the efficacy of tocilizumab monotherapy in large vessel giant cell arteritis
Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 6-7
-
Metabolic Syndrome: A Predisposing Factor for Rheumatoid Arthritis
Journal of Rheumatology
-
Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period
RMD open, Vol. 10, Núm. 2
2023
-
Abatacept in usual and in non-specific interstitial pneumonia associated with rheumatoid arthritis
European Journal of Internal Medicine
-
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
Seminars in Arthritis and Rheumatism, Vol. 58
-
Challenges in the diagnosis of polymyalgia rheumatica and related giant cell arteritis
Expert Review of Clinical Immunology, Vol. 19, Núm. 5, pp. 517-526
-
Classifying extracranial large-vessel giant cell arteritis using the new 2022 American College of Rheumatology/EULAR classification criteria: comment on the article by Ponte et al
Arthritis and Rheumatology
-
Co-occurrence of giant cell arteritis in patients with polymyalgia rheumatica. Comment on the article by Nielsen AW, et al
Seminars in Arthritis and Rheumatism
-
Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 910-915
-
Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 864-869
-
Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain
Frontiers in Immunology, Vol. 14
-
Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Epidemiology and clinical domains of Behçet's disease in the Cantabria region, Northern Spain
Clinical and experimental rheumatology, Vol. 41, Núm. 10, pp. 1991-1997
-
Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?
International Journal of Molecular Sciences, Vol. 24, Núm. 17
-
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836
-
Polymyalgia rheumatica: when should we suspect an underlying large vessel vasculitis?
Clinical and experimental rheumatology
-
Positron Emission Computed Tomography Spectrum of Large Vessel Vasculitis in a Tertiary Center: Differences in 18F-fluorodeoxyglucose Uptake between Large Vessel Vasculitis with Predominant Cranial and Extracranial Giant Cell Arteritis Phenotypes
Journal of Clinical Medicine, Vol. 12, Núm. 19